DOCSLIB.ORG

An Index of Syndromes and Their Anaesthetic Implications

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
An Index of Syndromes and Their Anaesthetic Implications AN INDEX OF SYNDROMES AND THEIR ANAESTHETIC IMPLICATIONS ANNE E.P. JONES AND D.A. PELTON PATIENTS often present for anaesthesia and surgery having been "labelled" with a diagnosis of some eponymous or rare syndrome. This index is an attempt to cata- logue as many syndromes as possible which have anaesthetic implications and to give an indication of their main features. It is hoped that it will be useful as a ready reference especially for those involved in paediatric anaesthesia, as many of these patients present in infancy or childhood. The information is presented in tabular form with a cross index of alternative names. Where possible anaesthetic references are given. Where no anaesthetic references exist those given refer to descriptive literature. SYnvno~Es Name Description Anaesthetic Implications Adrenogenital syndrome Inability to synthesize All need hydrocortisone even if not salt- hydrocortisone. Viriliza- losing. Check electrolytes ( 1 ) tion of female Albers-SchtJnberg Brittle bones, pathologi- Anaemia from marrow sclerosis. Hepa- disease (marble bone cal fractures tos~lenomegaly. Care in positioning disease or osteopetrosis) and restraint ( 2 ) Albright-Butler Renal tubular acidosis Correct electrolytes to within normal syndrome hypokalaemia. Renal Limits. Renal impairment (3) calculi Albright's osteo- Ectopic bone formation. Hypocalcaemia - possible ECG conduc- dystrophy (pseudo- Mental retardation tion defects, neuromuscular problems. hypoparathyroidism ) Convulsions (4) Alport syndrome Nephritis and nerve deaf- Renal failure in 2nd--Srd decade. Care ness. Renal pathology with renally excreted drugs (6) variable Alstr6m syndrome Obesity, blindness by Renal impairment. Management of seven years. Hearing loss. diabetes and obesity Diabetes after puberity - glomerulosclerosis Amyotonia congenita Anterior horn cell Sensitive to thiopentone ( reduced ( infantile muscular degeneration muscle mass ) and respiratory depress- atrophy ) ants. Care with muscle relaxants (7-10) Anne E.P. Jones, M.B., B.S., F.F.A.R.C.S. (Fellow), D.A. Pelton, M.D., F.R.C.P. (C) (Senior Anaesthetist) Department of Anaesthesia, The Hospital for Sick Children, Toronto and The University of Toronto. Our grateful thanks are due to Miss Sheree Coates for her secretarial assistance. 207 Canad. Anaesth. See. J., vol. 23, no. 2, March 1976 208 CANADIAN ANAESTHETISTS'SOCIETY JOURNAL Name Description Anaesthetic Implications Amyotropic lateral Degeneration of motor Avoid succinylcholine. Possible K + sclerosis neurones release and cardiac arrest. Minimal thiopentone and curare. Avoid respira- tory depressants ( 11 ) Analbuminaemia Almost absent albumin Very sensitive to protein bound drugs 4-100 mg~; including thiopentone, coumarin anti- coagulants, curare Andersen's disease Debrancher enzyme Possibility of hypoglycaemia under ( Glycogen storage deficiency anaesthesia disease IV) Aperts syndrome (acro- Craniosynostosis Difiqcult intubation. Possibly raised cephalosyndactyly) intracranial pressure, associated con- genital heart disease ( 13 ) hrthrogryposis Multiple congenital Ten per cent have congenital heart multiplex contractures disease. Minimal thiopentone required - muscles replaced by fat. Possible air- way problem with mandible (14) Asplenia syndrome Absent spleen, bilateral Very complex cardiovascular anomalies, visceral right sidedness present with cyanosis and heart failure (15) Ataxia-telangiectasia Cerebellar ataxia. Skin Defective immunity - recurrent chest and conjunctival telan- and sinus infections. Bronchiectasis giectasia. Decreased (16) serum IgA and IgE. 10 per cent develop reticule- endothelial malignancy Beckwith syndrome Birth weight > 4,000 gm Persistent severe neonatal hypoglycae- (infantile gigantism ) macroglossia and mia. Airway problems ( 17, 18 ) exomphalos Blackfan-Diamond Congenital idiopathic Liver and spleen enlarged. Hypersplen- syndrome red cell aplasia ism thrombocytopenia. Steroid therapy required ( 19 ) Bowen's syndrome Hepatomegaly and neo- Hypoprothrombinaemia. Care with ( eerebrohepatorenal natal jaundice. Polycystic renally excreted drugs and muscle syndrome) kidneys. Associated con- relaxants (20) genital heart disease. Muscular hypotonia Carpenter's syndrome Cranial synostosis. Hypoplastic mandible. Possibly difficult Associated congenital intubation (13) heart disease Central core disease Muscular dystrophy See amyotonia congenita (7-10) Chediak-Higashi Partial albinism Steroid tberapy. Recurrent chest infec- syndrome immunodeficiency tion. Thrombocytopenia - may require hepatosplenomegaly platelets ( 21 ) ~IONES & PELTON: INDEX OF SYNDROMES 209 Name Description Anaesthetic Implications Cherubism Tumourous lesion of Intubation may be extremely difficult. mandibles and maxillae May require tracheostomy for acute with intraoral masses. respiratory distress. Profuse bleeding at May cause respiratory surgery ( 22 ) distress Chotzen syndrome Craniosynostosis May be difficult intubation. Associated renal anomalies and possible impaired renal excretion of drugs (13) Christ-Siemens Absent sweating - heat Cannot control temperature by sweat- Touraine syndrome intolerance ing. Persistent upper respiratory and ( anhidrotic ectodermal chest infection due to poor mucus for- dysplasia) mation (23) Chronic granulomatous Inherited disorder of Hepatomegaly in 95 per cent. Poor pul- disease leucocyte function. monary function. Avoid infection-strict Recurrent infections with asepsis ( '24 ) non-pathogenic organisms Collagen diseases: Systemic connective Often have pulmonary infiltration or dermatomyositis, diseases frequently fibrosis. May have temporomandibular rheumatoid arthritis, treated with steroids. or cricoarytenoid arthritis causing air- systemic lupus Osteoporosis and fatty way and intubation difficuhies. Anae- erythematosus, infiltration of muscle. mia common. Risk of fat embolism after polyarteritis nodosa Variable systemic osteotomy, fracture or minor trauma involvement (5, 86, 87) Conradfs syndrome Chondrodystrophy wifla Problems are those of associated renal contractures, saddle nose, and cardiac disease (25) mental retardation. As- sociated congenital heart disease and renal anomalies Cretinism Absent thyroid tissue or Airway problems - large tongue, goitre. ( congenital defective synthesis Respiratory centre very sensitive to de- hypothyroidism ) thyroxine and goitre pression. CO 2 retention common. Hypo- glycaemia, hyponatraemia, hypoten- sion. Low cardiac output. Transfusion poorly tolerated ( 26 ) Cri-Du-Chat syndrome Chromosome 5-P abnor- Airway problems - stridor, laryngoma- mal. Abnormal cry, lacia. Possibly difficult intubation (27) microcephaly microgna- thia. Congenital heart disease C,'ouzon disease Craniosynostosis Possibly difficult intubation. Severe blood loss with cranial operation (13) Cutis laxa Elastic fibre degeneration Pulmonary infection, emphysenaa and pendulous skin, frequent corpulmona]e. Poor tissues - I.V. dif- hernias. Emphysema and ficult to maintain. Excess of soft tissues cor-pulnaonale. Arterial around larynx may lead to respiratory fragility obstruction ( 28, 29) 210 CANADIAN ANAESTHETISTS'SOCIETY JOURNAL Name Description Anaesthetic Implications Di George's syndrome Absent thymus and para- Recurrent chest infections. Hypopara- ( 3rd & 4th Arch thyroids. Immune de- thyroidism. Low Ca + + and tetany. syndrome ) ficiency. Susceptibility to Stridor. Aortic arch abnormalities and fungal and viral infec- reduced cardiac output. Donor blood tions. Treated by foetal must be irradiated with 3000 rads to thynfie transplants prevent graft-versus-host reaction (30) Down's syndrome Microcephaly. Small Difficult airway - large tongue, small ( mongolism ) nasopharynx. Hyptonia. mouth. Risk of laryngeal spasm especi- Sixty per cent have con- ally on extubation. Problems of cardiac genital heart disease. anomalies (31, 27 ) Duodenal atresia in some. Cervical spine abnor- malities Duchenne muscular Muscular dystrophy with As for Amyotonia congenitaplus cardiac dystrophy frequent cardiac muscle involvement. Minimal drug dosage. involvement. Usually die Avoid respiratory depressants, muscle in 2nd decade relaxants. Post-operative I.P.P.V. may be required (7-10) Edward's syndrome Congenital heart disease Possible difficult intubation. Care with (Trisomy 18(E)) in 95 per cent. Microgna- renally excreted drugs (27) thia in 80 per cent. Renal malformations 50-80 per cent. Usually die in infancy Ehlers-Danlos Collagen abnormality CVS - spontaneous rupture of vessels. syndrome with hyperelasticity and Angiogram 1 per cent mortality. ECG fragile tissues. Dissecting conduction abnormalities. I.V. difficult aneurysm of aorta. to maintain - haematoma. Poor tissues Fragility of other blood and clotting defect lead to haemorrhage vessels. Bleeding dia- especially G.I. tract. Spontaneous thesis ? cause pneumothorax ( 28, 29 ) Ellis-Van-Creveld Ectodermal defects, Chest wall anomalies lead to poor lung syndrome skeletal anomalies. 50 function. May have abnormal maxilla ( Chondroectodermal per cent have congenital and upper lip, hepatosplenomegaly dysplasia ) heart disease, usually (32) septal Epidermolysis Erosions and blisters Airway - oral lesions, adhesion of bullosa from minor skin trauma tongue. Ketamine is recommended or use small oral tube to avoid laryngeal trauma. Avoid skin tramna from tapes. History of steroid therapy. Check for porphyria. ( Similar skin lesions) (33) Fabry's disease Lipid storage disease CVS - hypertension, myocardial ischae- mia ( before 3rd or 4th decade ). Renal failure
Load more

Recommended publications
  • Benign Fibro-Osseous Lesions Plus…
    “Vision is the art of seeing things invisible.” Jonathan Swift 1667 - 1745 Benign Fibro-osseous Lesions Plus… Steven R. Singer, DDS [email protected] 212.305.5674 Benign Fibro-osseous Lesions Fibrous Dysplasia A group of lesions in which normal bone is Localized change in bone metabolism replaced initially by fibrous connective tissue Normal cancellous bone is replaced by Over time, the lesion is infiltrated by osteoid fibrous connective tissue and cementoid tissue The connective tissue contains varying amounts of abnormal bone with irregular This is a benign and idiopathic process trabeculae Trabeculae are randomly oriented. (Remember that normal trabeculae are aligned to respond to stress) Fibrous Dysplasia Fibrous Dysplasia Lesions may be solitary (monostotic) or Fibrous dysplasia is non-hereditary involve more than one bone (polyostotic) Caused by a mutation in a somatic cell. Monostotic form accounts for 70% of all Extent of lesions depends on the timing of cases the mutation. Polyostotic form is more common in the first If the mutation occurs earlier, the disease decade will be more widespread throughout the M=F except in McCune-Albright syndrome, body. An example is McCune-Albright which is almost exclusively found in females Syndrome 1 Fibrous Dysplasia Fibrous Dysplasia McCune-Albright Syndrome • Monostotic and polyostotic forms usually -Almost exclusively begins in the second decade of life females -Polyostotic fibrous • Slow, painless expansion of the jaws dysplasia • Patients may complain of swelling or have
    [Show full text]
  • Abstracts from the 9Th Biennial Scientific Meeting of The
    International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):15 DOI 10.1186/s13633-017-0054-x MEETING ABSTRACTS Open Access Abstracts from the 9th Biennial Scientific Meeting of the Asia Pacific Paediatric Endocrine Society (APPES) and the 50th Annual Meeting of the Japanese Society for Pediatric Endocrinology (JSPE) Tokyo, Japan. 17-20 November 2016 Published: 28 Dec 2017 PS1 Heritable forms of primary bone fragility in children typically lead to Fat fate and disease - from science to global policy a clinical diagnosis of either osteogenesis imperfecta (OI) or juvenile Peter Gluckman osteoporosis (JO). OI is usually caused by dominant mutations affect- Office of Chief Science Advsor to the Prime Minister ing one of the two genes that code for two collagen type I, but a re- International Journal of Pediatric Endocrinology 2017, 2017(Suppl 1):PS1 cessive form of OI is present in 5-10% of individuals with a clinical diagnosis of OI. Most of the involved genes code for proteins that Attempts to deal with the obesity epidemic based solely on adult be- play a role in the processing of collagen type I protein (BMP1, havioural change have been rather disappointing. Indeed the evidence CREB3L1, CRTAP, LEPRE1, P4HB, PPIB, FKBP10, PLOD2, SERPINF1, that biological, developmental and contextual factors are operating SERPINH1, SEC24D, SPARC, from the earliest stages in development and indeed across generations TMEM38B), or interfere with osteoblast function (SP7, WNT1). Specific is compelling. The marked individual differences in the sensitivity to the phenotypes are caused by mutations in SERPINF1 (recessive OI type obesogenic environment need to be understood at both the individual VI), P4HB (Cole-Carpenter syndrome) and SEC24D (‘Cole-Carpenter and population level.
    [Show full text]
  • Exostoses, Enchondromatosis and Metachondromatosis; Diagnosis and Management
    Acta Orthop. Belg., 2016, 82, 102-105 ORIGINAL STUDY Exostoses, enchondromatosis and metachondromatosis; diagnosis and management John MCFARLANE, Tim KNIGHT, Anubha SINHA, Trevor COLE, Nigel KIELY, Rob FREEMAN From the Department of Orthopaedics, Robert Jones Agnes Hunt Hospital, Oswestry, UK We describe a 5 years old girl who presented to the region of long bones and are composed of a carti- multidisciplinary skeletal dysplasia clinic following lage lump outside the bone which may be peduncu- excision of two bony lumps from her fingers. Based on lated or sessile, the knee is the most common clinical examination, radiolographs and histological site (1,10). An isolated exostosis is a common inci- results an initial diagnosis of hereditary multiple dental finding rarely requiring treatment. Disorders exostosis (HME) was made. Four years later she developed further lumps which had the radiological associated with exostoses include HME, Langer- appearance of enchondromas. The appearance of Giedion syndrome, Gardner syndrome and meta- both exostoses and enchondromas suggested a possi- chondromatosis. ble diagnosis of metachondromatosis. Genetic testing Enchondroma are the second most common be- revealed a splice site mutation at the end of exon 11 on nign bone tumour characterised by the formation of the PTPN11 gene, confirming the diagnosis of meta- hyaline cartilage in the medulla of a bone. It occurs chondromatosis. While both single or multiple exosto- most frequently in the hand (60%) and then the feet. ses and enchondromas occur relatively commonly on The typical radiological features are of a well- their own, the appearance of multiple exostoses and defined lucent defect with endosteal scalloping and enchondromas together is rare and should raise the differential diagnosis of metachondromatosis.
    [Show full text]
  • Phenotypic and Genotypic Characterisation of Noonan-Like
    1of5 ELECTRONIC LETTER J Med Genet: first published as 10.1136/jmg.2004.024091 on 2 February 2005. Downloaded from Phenotypic and genotypic characterisation of Noonan-like/ multiple giant cell lesion syndrome J S Lee, M Tartaglia, B D Gelb, K Fridrich, S Sachs, C A Stratakis, M Muenke, P G Robey, M T Collins, A Slavotinek ............................................................................................................................... J Med Genet 2005;42:e11 (http://www.jmedgenet.com/cgi/content/full/42/2/e11). doi: 10.1136/jmg.2004.024091 oonan-like/multiple giant cell lesion syndrome (NL/ MGCLS; OMIM 163955) is a rare condition1–3 with Key points Nphenotypic overlap with Noonan’s syndrome (OMIM 163950) and cherubism (OMIM 118400) (table 1). N Noonan-like/multiple giant cell lesion syndrome (NL/ Recently, missense mutations in the PTPN11 gene on MGCLS) has clinical similarities with Noonan’s syn- chromosome 12q24.1 have been identified as the cause of drome and cherubism. It is unclear whether it is a Noonan’s syndrome in 45% of familial and sporadic cases,45 distinct entity or a variant of Noonan’s syndrome or indicating genetic heterogeneity within the syndrome. In the cherubism. 5 study by Tartaglia et al, there was a family in which three N Three unrelated patients with NL/MGCLS were char- members had features of Noonan’s syndrome; two of these acterised, two of whom were found to have mutations had incidental mandibular giant cell lesions.3 All three in the PTPN11 gene, the mutation found in 45% of members were found to have a PTPN11 mutation known to patients with Noonan’s syndrome.
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Saethre-Chotzen Syndrome
    Saethre-Chotzen syndrome Authors: Professor L. Clauser1 and Doctor M. Galié Creation Date: June 2002 Update: July 2004 Scientific Editor: Professor Raoul CM. Hennekam 1Department of craniomaxillofacial surgery, St. Anna Hospital and University, Corso Giovecca, 203, 44100 Ferrara, Italy. [email protected] Abstract Keywords Disease name and synonyms Excluded diseases Definition Prevalence Management including treatment Etiology Diagnostic methods Genetic counseling Antenatal diagnosis Unresolved questions References Abstract Saethre-Chotzen Syndrome (SCS) is an inherited craniosynostotic condition, with both premature fusion of cranial sutures (craniostenosis) and limb abnormalities. The most common clinical features, present in more than a third of patients, consist of coronal synostosis, brachycephaly, low frontal hairline, facial asymmetry, hypertelorism, broad halluces, and clinodactyly. The estimated birth incidence is 1/25,000 to 1/50,000 but because the phenotype can be very mild, the entity is likely to be underdiagnosed. SCS is inherited as an autosomal dominant trait with a high penetrance and variable expression. The TWIST gene located at chromosome 7p21-p22, is responsible for SCS and encodes a transcription factor regulating head mesenchyme cell development during cranial tube formation. Some patients with an overlapping SCS phenotype have mutations in the FGFR3 (fibroblast growth factor receptor 3) gene; especially the Pro250Arg mutation in FGFR3 (Muenke syndrome) can resemble SCS to a great extent. Significant intrafamilial
    [Show full text]
  • “Leprechaunism” with a Novel Mutation in the Insulin Receptor Gene
    Case Report A case of Donohue syndrome “Leprechaunism” with a novel mutation in the insulin receptor gene Birgül Kirel1, Özkan Bozdağ2, Pelin Köşger2, Sultan Durmuş Aydoğdu2, Eylem Alıncak2, Neslihan Tekin3 1Osmangazi University, Faculty of Medicine, Department of Pediatrics, Division of Pediatric Endocrinology, Eskişehir, Turkey 2Osmangazi University, Faculty of Medicine, Department of Pediatrics, Division of General Pediatrics, Eskişehir, Turkey 3Osmangazi University, Faculty of Medicine, Department of Pediatrics, Division of Neonatalogy, Eskişehir, Turkey Cite this article as: Kirel B, Bozdağ Ö, Köşger P, Durmuş Aydoğdu S, Alıncak E, Tekin N. A case of Donohue syndrome “Leprechaunism” with a novel mutation in the insulin receptor gene. Turk Pediatri Ars 2017; 52: 226-30. Abstract She was diagnosed as having Donohue syndrome. Metformin and continuous nasogastric feeding were administrated. During fol- Donohue syndrome (Leprechaunism) is characterized by severe low-up, relatively good glycemic control was obtained. However, insulin resistance, hyperinsulinemia, postprandial hyperglycemia, severe hypertrophic obstructive cardiomyopathy and severe malnu- preprandial hypoglycemia, intrauterine and postnatal growth retar- trition developed. She died aged 75 days of severe heart failure and dation, dysmorphic findings, and clinical and laboratory findings pneumonia. Her insulin receptors gene analysis revealed a com- of hyperandrogenemia due to homozygous or compound heterozy- pound heterozygous mutation. One of these mutations was a p.R813 gous inactivating mutations in the insulin receptor gene. A female (c.2437C>T) mutation, which was defined previously and shown also newborn presented with lack of subcutaneous fat tissue, bilateral in her father, the other mutation was a novel p.777-790delVAAF- simian creases, hypertrichosis, especially on her face, gingival hy- PNTSSTSVPT mutation, also shown in her mother.
    [Show full text]
  • MEDICAL GENETICS RESIDENCY PROGRAM Department of Pediatrics
    MEDICAL GENETICS RESIDENCY PROGRAM Department of Pediatrics University of Michigan Health Systems (734) 763-6767 1500 E. Medical Center Drive (734) 763-6561 (fax) D5240 MPB Ann Arbor, MI 48109-5718 Biochemical Genetics Goals and Objectives Director: Drs. Ayesha Ahmad and Shane C. Quinonez The goals and objectives of the Biochemical Genetics Clinic rotation in the Medical Genetics Residency Program are to provide the resident with exposure to all aspects of care of metabolic disease and counseling in accordance with the Residency Review Committee for Medical Genetics expectations and to fulfill criteria for board eligibility by the American Board of Medical Genetics. Patient Care The resident will become familiar with the evaluation, diagnosis and management of urea cycle disorders, organic acidemias, disorders of carbohydrate and lipid metabolism and numerous other inborn errors of metabolism (IEMs). Residents will gain exposure in performing and expertise in interpreting biochemical analyses relevant to the diagnosis and management of human genetic diseases. By the end of the rotation the resident should be able to identify signs and symptoms of IEMs, formulate a differential diagnosis, order appropriate tests and recognize normal variants and complex patterns of metabolites. Residents will be able to manage acute metabolic crises and provide chronic management of patients with an IEM. Residents should be able to interpret NBS results, collaborate with the primary provider to act upon results in a timely manner, develop a differential diagnosis and order appropriate confirmatory testing and communicate results to families. Medical Knowledge Through coursework and didactic sessions with attending physicians, residents will become familiar with fundamental concepts, molecular biology and biochemistry relevant to IEMs.
    [Show full text]
  • Cherubism As a Systemic Skeletal Disease
    Morice et al. BMC Musculoskeletal Disorders (2020) 21:564 https://doi.org/10.1186/s12891-020-03580-z CASE REPORT Open Access Cherubism as a systemic skeletal disease: evidence from an aggressive case Anne Morice1,2,3,4*, Aline Joly3,4, Manon Ricquebourg5,6, Gérard Maruani2,7,8, Emmanuel Durand9, Louise Galmiche2,10, Jeanne Amiel2,11, Yoann Vial12,13, Hélène Cavé12,13, Kahina Belhous14, Marie Piketty15, Martine Cohen-Solal6, Ariane Berdal1,16, Corinne Collet5,6, Arnaud Picard1,2,3,4, Amelie E. Coudert1,6,16† and Natacha Kadlub1,2,3,4† Abstract Background: Cherubism is a rare autosomal dominant genetic condition caused by mutations in the SH3BP2 gene. This disease is characterized by osteolysis of the jaws, with the bone replaced by soft tissue rich in fibroblasts and multinuclear giant cells. SH3BP2 is a ubiquitous adaptor protein yet the consequences of SH3BP2 mutation have so far been described as impacting only face. Cherubism mouse models have been generated and unlike human patients, the knock-in mice exhibit systemic bone loss together with a systemic inflammation. Case presentation: In light of these observations, we decided to search for a systemic cherubism phenotype in a 6-year-old girl with an aggressive cherubism. We report here the first case of cherubism with systemic manifestations. Bone densitometry showed low overall bone density (total body Z-score = − 4.6 SD). Several markers of bone remodelling (CTx,BALP,P1NP)aswellasinflammation(TNFα and IL-1) were elevated. A causative second-site mutation in other genes known to influence bone density was ruled out by sequencing a panel of such genes.
    [Show full text]
  • SKELETAL DYSPLASIA Dr Vasu Pai
    SKELETAL DYSPLASIA Dr Vasu Pai Skeletal dysplasia are the result of a defective growth and development of the skeleton. Dysplastic conditions are suspected on the basis of abnormal stature, disproportion, dysmorphism, or deformity. Diagnosis requires Simple measurement of height and calculation of proportionality [<60 inches: consideration of dysplasia is appropriate] Dysmorphic features of the face, hands, feet or deformity A complete physical examination Radiographs: Extremities and spine, skull, Pelvis, Hand Genetics: the risk of the recurrence of the condition in the family; Family evaluation. Dwarf: Proportional: constitutional or endocrine or malnutrition Disproportion [Trunk: Extremity] a. Height < 42” Diastrophic Dwarfism < 48” Achondroplasia 52” Hypochondroplasia b. Trunk-extremity ratio May have a normal trunk and short limbs (achondroplasia), Short trunk and limbs of normal length (e.g., spondylo-epiphyseal dysplasia tarda) Long trunk and long limbs (e.g., Marfan’s syndrome). c. Limb-segment ratio Normal: Radius-Humerus ratio 75% Tibia-Femur 82% Rhizomelia [short proximal segments as in Achondroplastics] Mesomelia: Dynschondrosteosis] Acromelia [short hands and feet] RUBIN CLASSIFICATION 1. Hypoplastic epiphysis ACHONDROPLASTIC Autosomal Dominant: 80%; 0.5-1.5/10000 births Most common disproportionate dwarfism. Prenatal diagnosis: 18 weeks by measuring femoral and humeral lengths. Abnormal endochondral bone formation: zone of hypertrophy. Gene defect FGFR fibroblast growth factor receptor 3 . chromosome 4 Rhizomelic pattern, with the humerus and femur affected more than the distal extremities; Facies: Frontal bossing; Macrocephaly; Saddle nose Maxillary hypoplasia, Mandibular prognathism Spine: Lumbar lordosis and Thoracolumbar kyphosis Progressive genu varum and coxa valga Wedge shaped gaps between 3rd and 4th fingers (trident hands) Trident hand 50%, joint laxity Pathology Lack of columnation Bony plate from lack of growth Disorganized metaphysis Orthopaedics 1.
    [Show full text]
  • Two Novel Mutations Identified in Familial Cases with Donohue
    ORIGINAL ARTICLE Two novel mutations identified in familial cases with Donohue syndrome Tzipora C. Falik Zaccai1,2, Limor Kalfon1, Aharon Klar3, Mordechai Ben Elisha4, Haggit Hurvitz3, Galina Weingarten5, Emelia Chechik6, Vered Fleisher Sheffer4, Raid Haj Yahya3, Gal Meidan5, Eva Gross-Kieselstein3, Dvora Bauman7, Sylvia Hershkovitz4, Yuval Yaron8, Avi Orr-Urtreger8 & Efrat Wertheimer5 1Institute of Human Genetics, Western Galilee Medical Center, Naharia, Israel 2Faculty of Medicine in Galilee, Bar-Ilan University, Safed, Israel 3Department of Pediatrics, Bikur Cholim General Hospital, affiliated with the Hebrew University-Hadassah Medical School, Jerusalem, Israel 4Department of Neonatology, Western Galilee Medical Center, Naharia, Israel 5Department of Pathology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel 6Sherutei Briut Clalit, Western Galilee District, Israel 7Department of Obstetrics and Gynecology, Bikur Cholim General Hospital, Jerusalem, Israel 8Genetics Institute, Tel Aviv Sourasky Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel Keywords Abstract Cardiomyopathy, Donohue syndrome, genotype–phenotype, insulin receptor. Donohue syndrome (DS) is a rare and lethal autosomal recessive disease caused by mutations in the insulin receptor (INSR) gene, manifesting marked insulin Correspondence resistance, severe growth retardation, hypertrichosis, and characteristic dysmor- Tzipora C. Falik-Zaccai, Institute of Human phic features. We report the clinical, molecular, and biochemical characterization Genetics, Western Galilee Medical Center – of three new patients with DS, and address genotype–phenotype issues playing a Naharia, P.O. Box 21, Naharia 22100. Israel. role in the pathophysiology of DS. A female infant born to first-degree cousins Tel: 972-50-7887-941; Fax: 972-4-9107553; Muslim Arab parents and two brothers born to first-degree cousins Druze parents E-mail: [email protected] presented classical features of DS with hypertrophic cardiomyopathy and died in Funding Information infancy.
    [Show full text]
  • Prevalence and Incidence of Rare Diseases: Bibliographic Data
    Number 1 | January 2019 Prevalence and incidence of rare diseases: Bibliographic data Prevalence, incidence or number of published cases listed by diseases (in alphabetical order) www.orpha.net www.orphadata.org If a range of national data is available, the average is Methodology calculated to estimate the worldwide or European prevalence or incidence. When a range of data sources is available, the most Orphanet carries out a systematic survey of literature in recent data source that meets a certain number of quality order to estimate the prevalence and incidence of rare criteria is favoured (registries, meta-analyses, diseases. This study aims to collect new data regarding population-based studies, large cohorts studies). point prevalence, birth prevalence and incidence, and to update already published data according to new For congenital diseases, the prevalence is estimated, so scientific studies or other available data. that: Prevalence = birth prevalence x (patient life This data is presented in the following reports published expectancy/general population life expectancy). biannually: When only incidence data is documented, the prevalence is estimated when possible, so that : • Prevalence, incidence or number of published cases listed by diseases (in alphabetical order); Prevalence = incidence x disease mean duration. • Diseases listed by decreasing prevalence, incidence When neither prevalence nor incidence data is available, or number of published cases; which is the case for very rare diseases, the number of cases or families documented in the medical literature is Data collection provided. A number of different sources are used : Limitations of the study • Registries (RARECARE, EUROCAT, etc) ; The prevalence and incidence data presented in this report are only estimations and cannot be considered to • National/international health institutes and agencies be absolutely correct.
    [Show full text]